Project Number 1R43AG079692-01 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Pharmacokinetic and pharmacodynamic assessment of peptide-based therapy DA1 for the treatment of Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) j. Metabolism and Bioenergetics Researcher and Organization Principal Investigator SCHILB, ANDREW LORING Principal Investigator First Name ANDREW LORING Principal Investigator Last Name SCHILB Awardee Organization JANUSQ, LLC Awardee State Ohio Contact PI Country United States Project Detail Funding Opportunity Announcement PA-21-259: PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) FY Overall Cost $259,584 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
